Biocon Limited (BOM:532523)
388.25
-21.90 (-5.34%)
At close: Dec 4, 2025
Biocon Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 523,977 | 408,948 | 315,392 | 246,192 | 399,173 | 484,623 | Upgrade
|
| Market Cap Growth | 34.57% | 29.66% | 28.11% | -38.32% | -17.63% | 51.44% | Upgrade
|
| Enterprise Value | 690,813 | 607,421 | 513,003 | 277,130 | 425,255 | 496,641 | Upgrade
|
| Last Close Price | 392.80 | 340.74 | 263.38 | 204.60 | 331.18 | 404.68 | Upgrade
|
| PE Ratio | 107.93 | 40.36 | 30.85 | 53.21 | 61.56 | 65.44 | Upgrade
|
| PS Ratio | 3.18 | 2.68 | 2.14 | 2.20 | 4.88 | 6.78 | Upgrade
|
| PB Ratio | 1.59 | 1.48 | 1.25 | 1.10 | 4.22 | 5.70 | Upgrade
|
| P/TBV Ratio | - | - | - | - | 5.61 | 7.54 | Upgrade
|
| P/FCF Ratio | 26.80 | 21.25 | 24.77 | 95.98 | - | - | Upgrade
|
| P/OCF Ratio | 12.60 | 10.07 | 10.68 | 13.29 | 33.93 | 41.79 | Upgrade
|
| EV/Sales Ratio | 4.19 | 3.98 | 3.48 | 2.48 | 5.20 | 6.95 | Upgrade
|
| EV/EBITDA Ratio | 20.03 | 19.44 | 15.68 | 10.43 | 21.74 | 30.06 | Upgrade
|
| EV/EBIT Ratio | 40.50 | 39.36 | 28.77 | 17.72 | 36.71 | 52.06 | Upgrade
|
| EV/FCF Ratio | 35.33 | 31.56 | 40.29 | 108.04 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.50 | 0.66 | 0.64 | 0.80 | 0.54 | 0.53 | Upgrade
|
| Debt / EBITDA Ratio | 4.79 | 5.77 | 4.91 | 6.73 | 2.61 | 2.70 | Upgrade
|
| Debt / FCF Ratio | 8.46 | 9.54 | 12.78 | 70.25 | - | - | Upgrade
|
| Asset Turnover | 0.28 | 0.27 | 0.27 | 0.31 | 0.42 | 0.43 | Upgrade
|
| Inventory Turnover | 1.23 | 1.22 | 1.22 | 1.29 | 1.52 | 1.36 | Upgrade
|
| Quick Ratio | 0.72 | 0.71 | 0.58 | 0.87 | 1.43 | 1.25 | Upgrade
|
| Current Ratio | 1.16 | 1.14 | 0.99 | 1.45 | 2.19 | 1.81 | Upgrade
|
| Return on Equity (ROE) | 2.55% | 5.39% | 5.43% | 4.02% | 8.58% | 10.65% | Upgrade
|
| Return on Assets (ROA) | 1.78% | 1.68% | 2.06% | 2.70% | 3.72% | 3.62% | Upgrade
|
| Return on Capital (ROIC) | 2.29% | 2.20% | 2.72% | 3.55% | 5.24% | 5.16% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.70% | 3.50% | 4.40% | 3.60% | 7.00% | 6.70% | Upgrade
|
| Earnings Yield | 0.93% | 2.48% | 3.24% | 1.88% | 1.62% | 1.53% | Upgrade
|
| FCF Yield | 3.73% | 4.71% | 4.04% | 1.04% | -1.31% | -0.74% | Upgrade
|
| Dividend Yield | 0.13% | 0.15% | 0.19% | 0.73% | 0.15% | - | Upgrade
|
| Payout Ratio | 13.99% | 5.92% | 19.85% | 12.95% | - | - | Upgrade
|
| Buyback Yield / Dilution | -3.69% | -0.11% | -0.08% | 0.04% | 0.03% | -0.80% | Upgrade
|
| Total Shareholder Return | -3.56% | 0.04% | 0.11% | 0.77% | 0.18% | -0.80% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.